Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Industrial Logistics Properties Trust | ILPT | Jan 23, 2025 | 3.72 | +1.64 |
Industrial Select Sector SPDR | XLI | Jan 23, 2025 | 141.67 | +1.01 |
Industrials ETF Vanguard | VIS | Jan 23, 2025 | 273.99 | +0.81 |
Infinera | INFN | Jan 23, 2025 | 6.62 | +0.46 |
InflaRx N.V | IFRX | Jan 23, 2025 | 2.37 | -5.20 |
Inflection Point Acquisition II | IPXX | Jan 23, 2025 | 11.85 | +2.60 |
Inflection Point Acquisition II Unit | IPXXU | Jan 23, 2025 | 12.95 | 0.00 |
Infobird | IFBD | Jan 23, 2025 | 2.14 | +2.39 |
Informatica | INFA | Jan 23, 2025 | 24.72 | -0.84 |
Information Services Group | III | Jan 23, 2025 | 3.23 | +0.62 |
Information Technology ETF Vanguard | VGT | Jan 23, 2025 | 646.34 | +0.17 |
Infosys ADR | INFY | Jan 23, 2025 | 21.78 | +0.79 |
InfuSystems | INFU | Jan 23, 2025 | 8.07 | +0.37 |
ING Group ADR | ING | Jan 23, 2025 | 16.73 | +2.26 |
Ingersoll Rand | IR | Jan 23, 2025 | 94.06 | -0.18 |
Ingevity | NGVT | Jan 23, 2025 | 47.99 | +1.57 |
Ingles Markets A | IMKTA | Jan 23, 2025 | 64.26 | +1.58 |
Ingram Micro Holding Corp | INGM | Jan 23, 2025 | 22.82 | 0.00 |
Ingredion | INGR | Jan 23, 2025 | 136.69 | +0.92 |
Inhibikase Therapeutics | IKT | Jan 23, 2025 | 2.83 | +1.07 |
Inhibrx Biosciences | INBX | Jan 23, 2025 | 13.09 | -3.75 |
INLIF | INLF | Jan 23, 2025 | 5.18 | 0.00 |
InMed Pharmaceuticals | INM | Jan 23, 2025 | 4.20 | +5.00 |
InMode | INMD | Jan 23, 2025 | 17.26 | +1.11 |
INmune Bio | INMB | Jan 23, 2025 | 7.88 | +2.74 |
Innate Pharma ADR | IPHA | Jan 23, 2025 | 1.67 | -5.65 |
Inno Holdings | INHD | Jan 23, 2025 | 5.21 | +2.56 |
Innodata | INOD | Jan 23, 2025 | 39.68 | -0.30 |
Innospec | IOSP | Jan 23, 2025 | 115.45 | +0.17 |
InnovAge | INNV | Jan 23, 2025 | 3.70 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.